Product Center
The launch meeting of the safety evaluation research project for the tetravalent influenza virus subunit vaccine after its launch was a complete success
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-09-25
- Views:
(Summary description)Recently, the launch meeting of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine post market safety evaluation research project was held in Lanzhou, Gansu.
The launch meeting of the safety evaluation research project for the tetravalent influenza virus subunit vaccine after its launch was a complete success
(Summary description)Recently, the launch meeting of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine post market safety evaluation research project was held in Lanzhou, Gansu.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-09-25 14:16
- Views:
Recently, the launch meeting of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine post market safety evaluation research project was held in Lanzhou, Gansu.
The post marketing safety evaluation research project of the tetravalent influenza virus subunit vaccine is a multicenter study led by the Jiangsu Provincial Center for Disease Control and Prevention, guided by the Jiangsu Provincial Center for Adverse Drug Reaction Monitoring, and jointly participated by the six provincial centers for disease control and prevention. The purpose is to evaluate the safety of the tetravalent influenza virus subunit vaccine after vaccination in an expanded population of 3 years old and above, improve the safety monitoring model for Chinese vaccines after market launch, establish a long-term active monitoring mechanism, and promote the vaccine regulatory system to move towards higher maturity goals.
Relevant information
-
Ab&B Bio Tech CO., LTD. JS invited to attend the China Ukraine Trade Cooperation SeminarDuring the visit, the China Uruguay Trade Cooperation Seminar, organized by the China Council for the Promotion of International Trade, was grandly held in Beijing on the 21st. Uruguayan President Lac - The kickoff meeting for the Phase I clinical trial of freeze-dried human rabies vaccine (human diploid cells) was successfully held 11-27
- Successfully selected as a national open topic! 11-15
- Ab&B Bio-Tech CO.,LTD.JS The delegation went to Brazil, Uruguay, Chile, and Spain to carry out multinational exchange and cooperation activities 11-06
- The launch ceremony of the four valent influenza virus subunit vaccine Huierkangxin was successfully held! 09-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
